Dong F, Liu Y, Yan W, Meng Q, Song X, Cheng B
Cell Mol Neurobiol. 2022; 43(5):1663-1683.
PMID: 36350538
PMC: 11412186.
DOI: 10.1007/s10571-022-01279-4.
Stepanova D, Byrne H, Maini P, Alarcon T
PLoS Comput Biol. 2021; 17(1):e1008055.
PMID: 33411727
PMC: 7817011.
DOI: 10.1371/journal.pcbi.1008055.
Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin A, Auerbach R
Angiogenesis. 2018; 21(3):425-532.
PMID: 29766399
PMC: 6237663.
DOI: 10.1007/s10456-018-9613-x.
Iqbal F, Szaraz P, Librach M, Gauthier-Fisher A, Librach C
Stem Cell Res Ther. 2017; 8(1):184.
PMID: 28807010
PMC: 5557530.
DOI: 10.1186/s13287-017-0631-1.
Chung J, Shum-Tim D
Cells. 2014; 1(4):1246-60.
PMID: 24710553
PMC: 3901123.
DOI: 10.3390/cells1041246.
H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
Sun Y, Su L, Wang Z, Xu Y, Xu X
BMC Cell Biol. 2013; 14:8.
PMID: 23433118
PMC: 3598793.
DOI: 10.1186/1471-2121-14-8.
Forty-year journey of angiogenesis translational research.
Cao Y, Arbiser J, DAmato R, DAmore P, Ingber D, Kerbel R
Sci Transl Med. 2011; 3(114):114rv3.
PMID: 22190240
PMC: 8265598.
DOI: 10.1126/scitranslmed.3003149.
A mouse model of the cornea pocket assay for angiogenesis study.
Tang Z, Zhang F, Li Y, Arjunan P, Kumar A, Lee C
J Vis Exp. 2011; (54).
PMID: 21876523
PMC: 3217638.
DOI: 10.3791/3077.
Increased lymphangiogenesis and hemangiogenesis in infant cornea.
Yuen D, Leu R, Sadovnikova A, Chen L
Lymphat Res Biol. 2011; 9(2):109-14.
PMID: 21688980
PMC: 3117239.
DOI: 10.1089/lrb.2011.0005.
The mouse cornea as a transplantation site for live imaging of engineered tissue constructs.
Poche R, Saik J, West J, Dickinson M
Cold Spring Harb Protoc. 2010; 2010(4):pdb.prot5416.
PMID: 20360370
PMC: 3057363.
DOI: 10.1101/pdb.prot5416.
A critical analysis of current in vitro and in vivo angiogenesis assays.
Staton C, Reed M, Brown N
Int J Exp Pathol. 2009; 90(3):195-221.
PMID: 19563606
PMC: 2697546.
DOI: 10.1111/j.1365-2613.2008.00633.x.
Biomechanical regulation of blood vessel growth during tissue vascularization.
Kilarski W, Samolov B, Petersson L, Kvanta A, Gerwins P
Nat Med. 2009; 15(6):657-64.
PMID: 19483693
DOI: 10.1038/nm.1985.
The Flk1-myr::mCherry mouse as a useful reporter to characterize multiple aspects of ocular blood vessel development and disease.
Poche R, Larina I, Scott M, Saik J, West J, Dickinson M
Dev Dyn. 2009; 238(9):2318-26.
PMID: 19253403
PMC: 2901875.
DOI: 10.1002/dvdy.21886.
Microcomputed tomography characterization of neovascularization in bone tissue engineering applications.
Young S, Kretlow J, Nguyen C, Bashoura A, Baggett L, Jansen J
Tissue Eng Part B Rev. 2008; 14(3):295-306.
PMID: 18657028
PMC: 2761680.
DOI: 10.1089/ten.teb.2008.0153.
In vivo models of angiogenesis.
Norrby K
J Cell Mol Med. 2006; 10(3):588-612.
PMID: 16989723
PMC: 3933145.
DOI: 10.1111/j.1582-4934.2006.tb00423.x.
Targeting neovascular pericytes in neurofibromatosis type 1.
Ozerdem U
Angiogenesis. 2005; 7(4):307-11.
PMID: 15886874
PMC: 1224744.
DOI: 10.1007/s10456-004-6643-3.
Current methods for assaying angiogenesis in vitro and in vivo.
Staton C, Stribbling S, Tazzyman S, Hughes R, Brown N, Lewis C
Int J Exp Pathol. 2004; 85(5):233-48.
PMID: 15379956
PMC: 2517524.
DOI: 10.1111/j.0959-9673.2004.00396.x.
Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.
Akhtar N, Padilla M, Dickerson E, Steinberg H, Breen M, Auerbach R
Neoplasia. 2004; 6(2):106-16.
PMID: 15140399
PMC: 1502086.
DOI: 10.1593/neo.03334.
COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity.
Cho C, Kammerer R, Lee H, Steinmetz M, Ryu Y, Lee S
Proc Natl Acad Sci U S A. 2004; 101(15):5547-52.
PMID: 15060279
PMC: 397420.
DOI: 10.1073/pnas.0307574101.
HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.
Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A
J Clin Invest. 2001; 108(3):399-405.
PMID: 11489933
PMC: 209363.
DOI: 10.1172/JCI13131.
